MYBPC3 rs74315358: Understanding This Rare Genetic Variant
The rs74315358 variant is a rare genetic change located within the MYBPC3 gene, which provides instructions for building proteins essential for heart muscle contraction. Research into this specific variant is limited, but it is categorized in clinical databases as a potential factor in the development of hypertrophic cardiomyopathy.
What each genotype means
Typical genetic profile
This genotype represents the most common sequence found in the general population for this specific location in the MYBPC3 gene. It is not associated with the pathogenic sarcomeric dysfunction linked to hypertrophic cardiomyopathy. Individuals with this genotype do not carry the specific variant identified as a risk factor in this context.
This is the predominant genotype found in the vast majority of the global population.
Increased cardiomyopathy risk
This genotype indicates the presence of a single copy of the variant, which is associated with an increased risk of developing autosomal dominant hypertrophic cardiomyopathy. Because this condition can involve variable age of onset and clinical severity, individuals with this result should discuss the findings with a cardiologist or genetic counselor to understand their personal health context. This variant is extremely rare in the general population.
This genotype is very rare, with an allele frequency reported as less than 0.00003 in large population databases like gnomAD.
High risk of severe cardiomyopathy
This genotype indicates the presence of two copies of the variant, which is associated with a significantly higher risk of severe, early-onset cardiac complications. Research on biallelic or homozygous pathogenic variants in MYBPC3 suggests a potential for severe infantile cardiomyopathy or other structural heart defects. Clinical evaluation by a specialist is strongly recommended for anyone with this genotype.
This genotype is exceptionally rare and is not typically observed in the general population.
What is the rs74315358 Variant?
The rs74315358 variant is a single-nucleotide polymorphism (SNP) found within the MYBPC3 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence. This specific variant is considered extremely rare in the general population, appearing at a frequency that makes it difficult to study in large-scale cohorts. Because it is so uncommon, much of the current understanding of this variant comes from clinical case studies rather than broad population-wide screenings. When a variant is this rare, researchers often look at its location within the gene to predict how it might affect the resulting protein. By analyzing the DNA sequence, scientists can determine if the change alters the structure of the protein or if it disrupts the instructions for building it entirely. While the variant is cataloged in major databases, its specific functional impact remains a subject of ongoing investigation in the field of cardiovascular genetics.
The Role of the MYBPC3 Gene
The MYBPC3 gene is responsible for producing cardiac myosin-binding protein C, a critical component of the sarcomere. The sarcomere is the basic contractile unit of muscle cells, and in the heart, it allows muscle fibers to slide past one another, enabling the heart to pump blood effectively. This protein acts as a structural stabilizer and a regulator of the contraction process. When the MYBPC3 gene functions correctly, it ensures that the heart muscle maintains its proper shape and rhythm. However, mutations in this gene can lead to the production of unstable or insufficient protein. This deficiency can disrupt the delicate balance of heart muscle contraction and relaxation. Because the heart is under constant mechanical stress, even minor disruptions in these structural proteins can have significant long-term consequences for cardiac health, potentially leading to the thickening of the heart muscle walls, a condition known as hypertrophic cardiomyopathy.
Clinical Associations and Evidence
The association between rs74315358 and hypertrophic cardiomyopathy is currently classified as having limited evidence. In clinical genetics, 'limited' means that while there are reports suggesting a link, there is not yet enough robust, peer-reviewed data to definitively confirm the variant as a primary cause of disease in all individuals. Many variants in the MYBPC3 gene are known to be pathogenic, meaning they are clearly linked to heart conditions, but each specific variant must be evaluated on its own merits. Because rs74315358 is so rare, it is challenging for researchers to gather enough data to reach a consensus on its clinical significance. Some studies may identify it in individuals with heart conditions, but it is important to distinguish between a variant that causes a disease and one that is simply present alongside it. Clinicians and researchers continue to monitor such variants to see if future data clarifies their role in cardiac health.
Interpreting Your Genetic Information
It is important to understand that having a rare variant does not automatically mean an individual will develop a specific health condition. Genetic testing results should always be interpreted within the context of a person's overall health, family history, and clinical symptoms. If you have received information about this variant, it is essential to discuss the findings with a qualified healthcare provider or a genetic counselor. They can help you understand what the current scientific literature says about the variant and whether it is relevant to your personal health situation. You should never use genetic data to make medical decisions, such as starting or stopping medications, without professional guidance. Genetic information is a tool for understanding biological predispositions, but it is only one piece of a much larger puzzle that includes lifestyle, environment, and other genetic factors that contribute to your overall well-being.
How common is this variant?
The rs74315358 variant is very rare, with a minor allele frequency (MAF) reported in gnomAD as less than 0.00003 across major global populations.
Frequently asked questions
What is hypertrophic cardiomyopathy?
Hypertrophic cardiomyopathy is a condition where the heart muscle becomes abnormally thick, which can make it harder for the heart to pump blood. It is often caused by genetic mutations that affect the proteins in heart muscle cells.
Does having this variant mean I have heart disease?
No, having a genetic variant does not guarantee that you will develop a disease. Many factors, including other genes and environmental influences, determine your health outcomes.
Should I be worried if I have this variant?
Genetic findings should be discussed with a doctor or genetic counselor who can review your personal and family medical history. They are the best resource for determining if a specific finding requires clinical follow-up.
Where can I find more information on MYBPC3?
You can visit resources like MedlinePlus Genetics or the NCBI Gene database for comprehensive, peer-reviewed information on the function and clinical significance of the MYBPC3 gene.
Sources & further reading
Educational information only, last refreshed 10/9/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs74315358?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in MYBPC3
A common founder mutation (c.2827-2851del25) in the MYBPC3 gene strongly associated with hypertrophic cardiomyopathy in South Asian populations.
Well-characterized founder variant (p.Pro955His) conferring autosomal dominant predisposition to adult-onset hypertrophic cardiomyopathy.
A well-known pathogenic variant associated with Hypertrophic Cardiomyopathy, which causes thickening of the heart muscle.
Variant associated with endurance-focused athletic performance and exercise-induced cardiac remodeling.